Multiple site involvement is linked to reduced survival times
Integration of these factors into risk stratification shows potential for therapy optimization
Abstract
Elevated initial WBC count and multiple site involvement independently predict shorter EFS in pediatric LCH. Integrating these markers into risk stratification could optimize therapies.